Resting-state Imaging and OSteoporosiS
Launched by UNIVERSITY HOSPITAL, CLERMONT-FERRAND · Jun 12, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different areas of the brain communicate with each other in women who have osteoporosis, a condition that weakens bones, especially after menopause. The study will include three groups of women: those who are healthy and postmenopausal, those with osteoporosis who have had a bone fracture, and those with osteoporosis without a fracture. Researchers want to understand if and how brain function might be linked to osteoporosis and fractures by using a special type of brain scan called resting-state functional MRI (rs-fMRI). Participants will also complete questionnaires and tests to check their thinking skills, quality of life, sleep, physical activity, pain, anxiety, and mood. A small biological sample will be taken to look at markers related to bone health.
Women who are 50 years or older and postmenopausal may be eligible to participate. Those with osteoporosis must have a diagnosis from their doctor, and healthy volunteers should not have osteoporosis based on a bone density test done as part of the study. All participants need to be able to give informed consent and be affiliated with French Social Security. The study excludes women with certain medical devices like pacemakers or those who cannot safely have an MRI scan. If you take part, you can expect to undergo brain imaging, answer questions about your health and lifestyle, and provide a small biological sample. This research is not yet recruiting but aims to better understand how brain activity relates to osteoporosis, which could help improve care in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria (patients):
- • Women aged 50 or over, with postmenopausal osteoporosis, fractured or not, diagnosed by their rheumatologist,
- • Able to give informed consent to participate in the research,
- • Affiliation with the French Social Security.
- Inclusion Criteria (healthy volunteers):
- • Women aged 50 or over,
- • Bone densitometry performed as part of the protocol, not suggestive of osteoporosis and validated by investigators,
- • Matched to patients by age, menopausal status, socio-educational level and manual laterality,
- • Able to give informed consent to participate in the research,
- • Affiliation with the French Social Security.
- • Registration or acceptance of registration in the national register of volunteers participating in Research.
- Exclusion Criteria (patient and healthy volunteers):
- • Presence of pacemaker,
- • Presence of medical devices (implants or prostheses),
- • Incompatibility of the patient with the safety criteria of the medical imaging center for carrying out magnetic resonance experiments at 3 Tesla,
- • Contraindications to the realization of MRI without injection such as claustrophobia proven, hearing aid, pacemaker wearers, wearing a brain clip,
- • Refusal to be informed in the event of the accidental discovery of an anomaly during the resting state functional magnetic resonance imaging,
- • Woman under legal protection or deprived of liberty,
- • Refusal to participation
About University Hospital, Clermont Ferrand
The University Hospital of Clermont-Ferrand is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. Renowned for its multidisciplinary approach, the hospital integrates cutting-edge scientific inquiry with patient care, fostering an environment that promotes collaboration among healthcare professionals, researchers, and academic partners. With a strong commitment to improving patient outcomes, the institution actively engages in a wide array of clinical studies, ranging from early-phase trials to large-scale interventions, aimed at addressing critical health challenges and enhancing treatment modalities. Its state-of-the-art facilities and expertise make it a pivotal contributor to clinical research in the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Clermont Ferrand, , France
Patients applied
Trial Officials
Marie-Eva Pickering
Principal Investigator
University Hospital, Clermont-Ferrand
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported